Tubuloglomerular feedback and renal function in mice with targeted deletion of the type 1 equilibrative nucleoside transporter

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 4, 2013, Pages

  Li, Lingli ^a   Mizel, Diane ^a   Huang, Yuning ^a   Eisner, Christoph ^a,b   Hoerl, Marion ^c   Thiel, Manfred ^b   Schnermann, Jurgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenosine; Blood pressure; Micropuncture; Plasma renin; Stop flow pressure

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE RECEPTOR; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; INOSINE; MESSENGER RNA; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEEDBACK SYSTEM; FEMALE; GENE DELETION; GENE EXPRESSION; GENOTYPE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEART RATE; HENLE LOOP; KIDNEY CIRCULATION; KIDNEY CONCENTRATING CAPACITY; KIDNEY FUNCTION; KIDNEY TUBULE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCH BIOPSY; RAT; URINE OSMOLALITY; WILD TYPE;

EID: 84874043055     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00581.2012     Document Type: Article

References (39)

1. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflügers Arch 447: 735-743, 2004.
2. -/- mice. Am J Physiol Heart Circ Physiol 299: H847-H856, 2010.
3. Castrop H, Huang Y, Hashimoto S, Mizel D, Hansen P, Theilig F, Bachmann S, Deng C, Briggs J, Schnermann J. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5=-nucleotidase/CD73-deficient mice. J Clin Invest 114: 634-642, 2004.
4. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7: 855-861, 2004.
5. Damaraju VL, Elwi AN, Hunter C, Carpenter P, Santos C, Barron GM, Sun X, Baldwin SA, Young JD, Mackey JR, Sawyer MB, Cass CE. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am J Physiol Renal Physiol 293: F200-F211, 2007.
6. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schonfeld C, Loffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505, 2005.
7. Elwi AN, Damaraju VL, Baldwin SA, Young JD, Sawyer MB, Cass CE. Renal nucleoside transporters: physiological and clinical implications. Biochem Cell Biol 84: 844-858, 2006.
8. Faulhaber-Walter R, Chen L, Oppermann M, Kim SM, Huang Y, Hiramatsu N, Mizel D, Kajiyama H, Zerfas P, Briggs JP, Kopp JB, Schnermann J. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 19: 722-730, 2008.
9. Graham K, Yao S, Johnson L, Mowles D, Ng A, Wilkinson J, Young JD, Cass CE. Nucleoside transporter gene expression in wild-type and mENT1 knockout mice. Biochem Cell Biol 89: 236-245, 2011.
10. Grenz A, Bauerle JD, Dalton JH, Ridyard D, Badulak A, Tak E, McNamee EN, Clambey E, Moldovan R, Reyes G, Klawitter J, Ambler K, Magee K, Christians U, Brodsky KS, Ravid K, Choi DS, Wen J, Lukashev D, Blackburn MR, Osswald H, Coe IR, Nurnberg B, Haase VH, Xia Y, Sitkovsky M, Eltzschig HK. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122: 693-710, 2012.
11. Hagemeier E, Kemper K, Boos KS, Schlimme E. On-line high-performance liquid affinity chromatography-high-performance liquid chromatography analysis of monomeric ribonucleoside compounds in biological fluids. J Chromatogr 282: 663-669, 1983.
12. Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 315: 1150-1157, 2005.
13. Huang DY, Vallon V, Zimmermann H, Koszalka P, Schrader J, Osswald H. Ecto-5=-nucleotidase (cd73)-dependent and-independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol 291: F282-F288, 2006.
14. Kawabata M, Haneda M, Wang T, Imai M, Takabatake T. Effects of a nucleoside transporter inhibitor, dilazep, on renal microcirculation in rats. Hypertens Res 25: 615-621, 2002.
15. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab 5: 63-84, 2004.
16. Li L, Lai EY, Huang YG, Eisner C, Mizel D, Wilcox CS, Schnermann JB. Renal afferent arteriolar and tubuloglomerular feedback reactivity in mice with conditional deletions of adenosine 1 receptors. Am J Physiol Renal Physiol 303: F1166-F1175, 2012.
17. Lovatt D, Xu Q, Liu W, Takano T, Smith NA, Schnermann J, Tieu K, Nedergaard M. Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci USA 109: 6265-6270, 2012.
18. Nakamoto H, Ogasawara Y, Kajiya F. Visualisation of the effects of dilazep on rat afferent and efferent arterioles in vivo. Hypertens Res 31: 315-324, 2008.
19. Ontyd J, Schrader J. Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr 307: 404-409, 1984.
20. Oppermann M, Friedman DJ, Faulhaber-Walter R, Mizel D, Castrop H, Enjyoji K, Robson SC, Schnermann J. Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. Am J Physiol Renal Physiol 294: F965-F970, 2008.
21. Oppermann M, Qin Y, Lai EY, Eisner C, Li L, Huang Y, Mizel D, Fryc J, Wilcox CS, Briggs J, Schnermann J, Castrop H. Enhanced tubuloglomerular feedback in mice with vascular overexpression of A1 adenosine receptors. Am J Physiol Renal Physiol 297: F1256-F1264, 2009.
22. Osswald H, Hermes HH, Nabakowski G. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int Suppl 12: S136-142, 1982.
23. Osswald H, Nabakowski G, Hermes H. Adenosine as a possible mediator of metabolic control of glomerular filtration rate. Int J Biochem 12: 263-267, 1980.
24. Osswald H, Spielman WS, Knox FG. Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 43: 465-469, 1978.
25. Palmer TM, Benovic JL, Stiles GL. Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor. J Biol Chem 271: 15272-15278, 1996.
26. Palmer TM, Stiles GL. Structure-function analysis of inhibitory adenosine receptor regulation. Neuropharmacology 36: 1141-1147, 1997.
27. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286: F590-F596, 2004.
28. Rose JB, Naydenova Z, Bang A, Ramadan A, Klawitter J, Schram K, Sweeney G, Grenz A, Eltzschig H, Hammond J, Choi DS, Coe IR. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge. Life Sci 89: 621-630, 2011.
29. Rosivall L, Mirzahosseini S, Toma I, Sipos A, Peti-Peterdi J. Fluid flow in the juxtaglomerular interstitium visualized in vivo. Am J Physiol Renal Physiol 291: F1241-F1247, 2006.
30. Schnermann J. Vascular tone as a determinant of tubuloglomerular feedback responsiveness. In: The Juxtaglomerular Apparatus, edited by Persson AE, Boberg U. Amsterdam, The Netherlands: Elsevier, 1988, p. 167-176.
31. Schnermann J, Todd KM, Briggs JP. Effect of dopamine on the tubuloglomerular feedback mechanism. Am J Physiol Renal Fluid Electrolyte Physiol 258: F790-F798, 1990.
32. Schnermann JB, Traynor T, Yang T, Huang YG, Oliverio MI, Coffman T, Briggs JP. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am J Physiol Renal Physiol 273: F315-F320, 1997.
33. Sollevi A, Ostergren J, Fagrell B, Hjemdahl P. Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. Acta Physiol Scand 121: 165-171, 1984.
34. Thomson S, Bao D, Deng A, Vallon V. Adenosine formed by 5=-nucleotidase mediates tubuloglomerular feedback. J Clin Invest 106: 289-298, 2000.
35. Vallon V, Osswald H. Dipyridamole prevents diabetes-induced alterations of kidney function in rats. Naunyn Schmiedebergs Arch Pharmacol 349: 217-222, 1994.
36. Williams EF. Plasticity of cardiovascular nucleoside transporters following chronic dipyridamole treatment. SAAS Bull Biochem Biotechnol 10: 19-24, 1997.
37. Wright FS, Schnermann J. Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide. J Clin Invest 53: 1695-1708, 1974.
38. Yang JN, Tiselius C, Dare E, Johansson B, Valen G, Fredholm BB. Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) 190: 63-75, 2007.
39. Yukimura T, Miura K, Ito K, Yamamoto K. Renal vascular effects of dilazep antagonized by 3-isobutyl-1-methyl-xanthine. J Cardiovasc Pharmacol 8: 649-655, 1986.